Core Viewpoint - As of September 18, a total of 149 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Significant Net Buying - The stock with the highest number of consecutive days of net buying is Tianpu Co., which has seen net buying for 13 consecutive trading days [1] - Other notable stocks with significant net buying days include Jiankangyuan, Shandong Publishing, Aima Technology, Mosi Co., Hunan Haili, Xiamen Guomao, Zhuojin Co., and Botuo Biotechnology [1]

Core Insights - As of September 17, a total of 98 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more [1] - The stock with the longest streak of net buying is Haotaitai, which has seen net purchases for 15 consecutive trading days [1] - Other notable stocks with significant net buying days include Tianpu Co., Health元, Shandong Publishing, Mousse Co., Aima Technology, Hunan Haili, Baida Group, and Huadian New Energy [1]

Core Insights - A total of 111 stocks in the Shanghai and Shenzhen markets have received net buying from major funds for five consecutive days or more as of September 16 [1] - The stock with the longest consecutive net buying days is Haotaitai, which has seen net buying for 14 consecutive trading days [1] - Other notable stocks with significant net buying days include Tianpu Co., CNOOC Engineering, Jianfeng Group, Jiankangyuan, Xingrong Environment, Shandong Publishing, Pudong Construction, and Hunan Haili [1]

Core Viewpoint - Health元's stock price has shown fluctuations, with a year-to-date increase of 15.36% but a recent decline in the last five trading days by 3.18% [1] Group 1: Financial Performance - For the first half of 2025, Health元 reported operating revenue of 7.898 billion yuan, a year-on-year decrease of 4.08%, while net profit attributable to shareholders increased by 1.10% to 785 million yuan [2] - Cumulative cash dividends since the A-share listing amount to 3.979 billion yuan, with 1.04 billion yuan distributed in the last three years [3] Group 2: Stock and Market Activity - As of September 16, Health元's stock price was 12.77 yuan per share, with a total market capitalization of 23.362 billion yuan [1] - The stock experienced a net outflow of 17.5091 million yuan from main funds, with significant selling pressure observed [1] Group 3: Shareholder Structure - As of June 30, 2025, Health元 had 76,300 shareholders, a decrease of 4.32% from the previous period, with an average of 23,991 circulating shares per shareholder, an increase of 4.52% [2] - The top circulating shareholder is Hong Kong Central Clearing Limited, holding 68.3785 million shares, an increase of 14.9969 million shares from the previous period [3]

Core Viewpoint - Health元's stock price has experienced fluctuations, with a year-to-date increase of 16.71% but a recent decline of 5.07% over the past five trading days [1] Company Overview - Health元 Pharmaceutical Group Co., Ltd. is located in Nanshan District, Shenzhen, Guangdong Province, and was established on December 18, 1992, with its listing date on June 8, 2001 [1] - The company operates as a comprehensive pharmaceutical enterprise, primarily engaged in the research, development, and production of traditional Chinese medicine, health products, and Western medicine [1] - The revenue composition includes: chemical preparations 47.71%, chemical raw materials and intermediates 31.97%, traditional Chinese medicine preparations 10.28%, diagnostic reagents and equipment 4.74%, health food 3.08%, biological products 1.20%, and others 0.86% [1] Financial Performance - For the first half of 2025, Health元 reported operating revenue of 7.898 billion yuan, a year-on-year decrease of 4.08%, while net profit attributable to shareholders increased by 1.10% to 785 million yuan [2] - Since its A-share listing, Health元 has distributed a total of 3.979 billion yuan in dividends, with 1.04 billion yuan distributed in the last three years [3] Shareholder Information - As of June 30, 2025, Health元 had 76,300 shareholders, a decrease of 4.32% from the previous period, with an average of 23,991 circulating shares per person, an increase of 4.52% [2] - The top ten circulating shareholders include Hong Kong Central Clearing Limited as the second-largest shareholder with 68.3785 million shares, an increase of 14.9969 million shares from the previous period [3]

Group 1 - The controlling shareholder of the company, Shenzhen Baiye Yuan Investment Co., Ltd., holds 89,565.37 million shares, accounting for 48.96% of the total issued share capital of 182,945.34 million shares [2] - Baiye Yuan Investment has released a pledge of 19.50 million shares, which represents 2.18% of its holdings and 1.07% of the company's total issued shares [2] - After the release of the pledge, Baiye Yuan Investment has no pledged shares remaining [3] Group 2 - As of the announcement date, the cumulative pledged shares of the controlling shareholder, Baiye Yuan Investment, are zero following the recent release [3] - The company will continue to monitor the pledge and release status of the shares held by its shareholders and will comply with relevant disclosure obligations [3]

Core Points - On September 8, Health元 announced that its controlling shareholder, Shenzhen Baiye Yuan Investment Co., Ltd., will release the pledge of 19.5 million unrestricted circulating shares to the Industrial and Commercial Bank of China, Shenzhen Hongwei Branch, on September 5, 2025 [2] Summary by Category - **Company Announcement** - Health元 disclosed the release of a pledge involving 19.5 million shares [2] - The pledge release has been completed with the China Securities Depository and Clearing Corporation Limited, Shanghai Branch [2] - **Shareholder Information** - The controlling shareholder involved in the pledge release is Shenzhen Baiye Yuan Investment Co., Ltd. [2]

Group 1 - Health元 announced the release of 19.5 million shares from pledge by 百业源投资 on September 5, 2023, with no subsequent pledge plans confirmed [1] - 百业源投资 holds approximately 896 million unrestricted circulating shares, accounting for 48.96% of the total issued share capital of Health元, which is about 1.829 billion shares [1] - For the first half of 2025, Health元's revenue composition shows that the pharmaceutical manufacturing sector accounts for 99.14%, while other businesses contribute 0.86% [1] Group 2 - As of the report, Health元's market capitalization is 24.5 billion yuan [2]

证券代码：600380 证券简称：健康元 公告编号：临 2025-065 健康元药业集团股份有限公司 关于股东部分股权解除质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●健康元药业集团股份有限公司（以下简称：本公司）控股股东深圳市百业源投 资有限公司（以下简称：百业源投资）持有本公司无限售流通股 89,565.37 万股，占本 公司已发行总股本（182,945.34 万股）48.96%。 健康元药业集团 关于股东部分股权解除质押公告 | | | 占其所 | 占公司 | | | | 剩余被质 | 剩余被质 押股份数 | 剩余被质 押股份数 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东名称 | 本次解质 | 持股份 | 总股本 | 解质时间 | 持股数量 | 持股 | 押股份数 | 量占其所 | 量占公司 | | | 股份 | | | | | 比例 | | | | | | | 比例 | 比例 | | | | 量 ...

Group 1 - The core viewpoint of the articles highlights the performance and financial metrics of Health元, indicating a positive trend in stock price and market activity [1][2][3] - As of September 5, Health元's stock price increased by 2.05% to 13.44 CNY per share, with a total market capitalization of 24.588 billion CNY [1] - Year-to-date, Health元's stock has risen by 21.41%, with notable increases of 8.21% over the last five trading days, 9.62% over the last twenty days, and 17.28% over the last sixty days [1] Group 2 - Health元's main business segments include chemical preparations (47.71%), chemical raw materials and intermediates (31.97%), traditional Chinese medicine preparations (10.28%), diagnostic reagents and equipment (4.74%), health food (3.08%), biological products (1.20%), and others (0.86%) [1] - As of June 30, 2025, Health元 reported a revenue of 7.898 billion CNY, a year-on-year decrease of 4.08%, while net profit attributable to shareholders increased by 1.10% to 785 million CNY [2] - The company has distributed a total of 3.979 billion CNY in dividends since its A-share listing, with 1.04 billion CNY distributed in the last three years [3]